跳至主要内容
临床试验/NL-OMON33949
NL-OMON33949已完成不适用

DYANA Study - Dynamic Annuloplasty System with Activation for the Treatment of Mitral Regurgitation - DYANA Study

MiCardia Corporation, Jody L. Errandi M.S., Director of Clinical0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1.This patient requires mitral valve repair with or without concomitant procedures such as coronary artery bypass or another valve reconstruction or replacement.
  • 2.This patient has been diagnosed with a diseased natural valve, based on
  • echocardiography and is a candidate for mitral valve repair.
  • 3.This patient is in satisfactory condition, based on the physical exam and investigator's experience, to be an average or better operative risk. (i.e., likely to survive one year postoperatively)

排除标准

  • 1. This patient is less than eighteen (18) years of age.
  • 2. This patient has a non-cardiac major or progressive disease, which in the investigators experience produces an unacceptable increased risk to the patient, or results in a life expectancy of less than twelve months.
  • 3. Patient who has heavily calcified annulus or leaflets.
  • 4. reoperation

研究者

发起方
MiCardia Corporation, Jody L. Errandi M.S., Director of Clinical

相似试验